Weight Loss
- Chemical Name: Tirzepatide
- Compound Type: Synthetic dual agonist peptide (GLP-1 + GIP)
- Molecular Formula: C₂₂₈H₃₄₁N₅₇O₆₈
- Molecular Weight: ~4,150–4,200 g/mol (depends on formulation and modifications)
- Peptide Class: Long-acting GLP-1/GIP dual agonist, engineered for enhanced metabolic activity and weight-loss research
Description:
Tirzepatide is a synthetic dual agonist peptide targeting GLP-1 and GIP receptors, recognized as one of the most promising compounds for weight management and metabolic research. By simultaneously modulating satiety pathways and enhancing insulin secretion, it helps reduce appetite, support fat loss, and improve glucose homeostasis.
Its mechanism promotes adipose tissue reduction, energy balance, and metabolic efficiency while offering potential synergistic benefits when studied alongside other peptides or lifestyle interventions. Tirzepatide is widely used in research exploring obesity, type 2 diabetes, glycemic regulation, and cardiometabolic risk reduction.
Research Applications:
- Fat Loss: Supports studies on adipose tissue reduction and body weight regulation.
- Blood Sugar Control: Investigates effects on glycemic control, insulin sensitivity, and metabolic homeostasis.
- Combination Therapies: Can be studied alongside other peptides or metabolic interventions for synergistic effects.
- Obesity & Metabolic Disorders: Explores mechanisms of action for potential interventions in obesity, type 2 diabetes, and related metabolic disorders.
Storage and Handling:
- Store at –20°C; short-term storage at 2–8°C is acceptable.
- Protect from light and keep vials tightly sealed.
- Use aseptic techniques and avoid repeated freeze-thaw cycles.
Product Specifications:
- Purity: ≥98% (HPLC certified)
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in sterile water, DMSO, or other polar solvents suitable for peptide research
Compliance Notice:
Tirzepatide is intended strictly for research and clinical investigation purposes and is not approved for human or veterinary use. This product has not been evaluated by the FDA or any other regulatory authority. Any unauthorized use is prohibited and may be subject to applicable laws. By purchasing, the buyer acknowledges that Tirzepatide will be used solely for controlled laboratory or physician-supervised research studies.
Reviews
There are no reviews yet.